As of 2025-05-15, the Fair Value of Pharmagreen Biotech Inc (PHBI) is -0.01 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.00 USD, the upside of Pharmagreen Biotech Inc is -787.93%.
With the market price of 0.00 USD and our fair value calculation, Pharmagreen Biotech Inc (PHBI) is not a good investment. Investing in PHBI stocks now will result in a potential loss of 787.93%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 5Y Avg | |
| Net income | -2.44 | -4.53 | -0.88 | -0.57 | -1.00 | -1.88 |
| YoY growth | -217.62% | -85.90% | 80.68% | 35.03% | -76.59% | -52.88% |
| Market Cap (mil) | 0.73 |
| P/E | |
| Forward P/E |
| EPS | -0.00 |
| Avg earnings growth rate | -52.88% |
| TTM earnings | -1.00 |